stockrowCencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
Follow COR
Alert me
Cencora, Inc. (COR) Return on equity
Cencora, Inc.'s return on equity over the twelve months to 30 September 2026 was 0.00%. Over the past ten years it has ranged from −1,206.7% (fiscal 2021) to 518.2% (fiscal 2022); the current reading is higher than 33% of that period. That is in line with the Medical Distribution industry median of 0.00% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | 0.00% | (122.67) |
| FY2025 | 122.7% | (85.05) |
| FY2024 | 207.7% | (265.54) |
| FY2023 | 473.3% | (44.92) |
| FY2022 | 518.2% | 1,724.91 |
| FY2021 | −1,206.7% | (890.17) |
| FY2020 | −316.6% | (344.87) |
| FY2019 | 28.3% | (36.54) |
| FY2018 | 64.9% | 47.47 |
| FY2017 | 17.4% | (86.63) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| ACH Accendra Health, Inc. compare | 72.6% |
| YI 111, Inc. Sponsored ADR compare | 12.3% |
| HSIC Henry Schein, Inc. compare | 10.7% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| COR Cencora, Inc. | 0.00% |
| CAH Cardinal Health, Inc. compare | −65.0% |
| COSM Cosmos Health Inc. compare | −104.0% |
| FOCL FocalTherics compare | −133.5% |
| MCK McKesson Corporation compare | −190.5% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement